1035 related articles for article (PubMed ID: 21029304)
1. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
2. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
[TBL] [Abstract][Full Text] [Related]
3. Nutritional related liver disease: targeting the endoplasmic reticulum stress.
Kammoun HL; Hainault I; Ferré P; Foufelle F
Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):575-82. PubMed ID: 19726979
[TBL] [Abstract][Full Text] [Related]
4. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
McPherson S; Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
J Hepatol; 2008 Dec; 49(6):1046-54. PubMed ID: 18752865
[TBL] [Abstract][Full Text] [Related]
6. SREBP-1c transcription factor and lipid homeostasis: clinical perspective.
Ferré P; Foufelle F
Horm Res; 2007; 68(2):72-82. PubMed ID: 17344645
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
8. Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway.
Guillet-Deniau I; Pichard AL; Koné A; Esnous C; Nieruchalski M; Girard J; Prip-Buus C
J Cell Sci; 2004 Apr; 117(Pt 10):1937-44. PubMed ID: 15039461
[TBL] [Abstract][Full Text] [Related]
9. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
Robichon C; Girard J; Postic C
Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
[TBL] [Abstract][Full Text] [Related]
10. SREBP transcription factors: master regulators of lipid homeostasis.
Eberlé D; Hegarty B; Bossard P; Ferré P; Foufelle F
Biochimie; 2004 Nov; 86(11):839-48. PubMed ID: 15589694
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
Endo M; Masaki T; Seike M; Yoshimatsu H
Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
[TBL] [Abstract][Full Text] [Related]
12. Role of ChREBP in hepatic steatosis and insulin resistance.
Denechaud PD; Dentin R; Girard J; Postic C
FEBS Lett; 2008 Jan; 582(1):68-73. PubMed ID: 17716660
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress: a new actor in the development of hepatic steatosis.
Flamment M; Kammoun HL; Hainault I; Ferré P; Foufelle F
Curr Opin Lipidol; 2010 Jun; 21(3):239-46. PubMed ID: 20463471
[TBL] [Abstract][Full Text] [Related]
14. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hepatic PPARgamma2 and lipogenic gene expression by melanocortin.
Poritsanos NJ; Wong D; Vrontakis ME; Mizuno TM
Biochem Biophys Res Commun; 2008 Nov; 376(2):384-8. PubMed ID: 18789887
[TBL] [Abstract][Full Text] [Related]
16. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.
Sekiya M; Yahagi N; Matsuzaka T; Najima Y; Nakakuki M; Nagai R; Ishibashi S; Osuga J; Yamada N; Shimano H
Hepatology; 2003 Dec; 38(6):1529-39. PubMed ID: 14647064
[TBL] [Abstract][Full Text] [Related]
17. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes.
Moldes M; Boizard M; Liepvre XL; Fève B; Dugail I; Pairault J
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):873-80. PubMed ID: 10585876
[TBL] [Abstract][Full Text] [Related]
18. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
19. Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanism.
Choi SM; Cho HJ; Cho H; Kim KH; Kim JB; Park H
Nucleic Acids Res; 2008 Nov; 36(20):6372-85. PubMed ID: 18838394
[TBL] [Abstract][Full Text] [Related]
20. Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice.
Frederico MJ; Vitto MF; Cesconetto PA; Engelmann J; De Souza DR; Luz G; Pinho RA; Ropelle ER; Cintra DE; De Souza CT
Scand J Gastroenterol; 2011 Nov; 46(11):1381-8. PubMed ID: 21936721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
